Cutaneous Adverse Events of Targeted Therapies for Hematolymphoid Malignancies.

Author: KwongBernice Y, RansohoffJulia D

Paper Details 
Original Abstract of the Article :
The identification of oncogenic drivers of liquid tumors has led to the rapid development of targeted agents with distinct cutaneous adverse event (AE) profiles. The diagnosis and management of these skin toxicities has motivated a novel partnership between dermatologists and oncologists in developi...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.clml.2017.07.005

データ提供:米国国立医学図書館(NLM)

Targeted Therapies for Hematolymphoid Malignancies: A New Frontier in Oncology

The field of oncology is constantly evolving, like a desert landscape where new oases of knowledge are constantly emerging. This study focuses on the cutaneous adverse events (AEs) associated with targeted therapies for hematolymphoid malignancies, exploring the delicate balance between fighting cancer and managing its side effects.

The authors highlight the growing importance of oncodermatology clinics, where dermatologists and oncologists collaborate to manage the skin toxicities associated with targeted therapies. It's like establishing a network of oases in a vast desert, providing vital support and resources to navigate the challenges of cancer treatment.

This study provides a comprehensive review of the cutaneous AEs associated with various targeted therapies, offering valuable insights for clinicians managing these complex cases. It's like a detailed map of the desert, guiding oncologists and dermatologists through the intricacies of skin toxicities.

Navigating the Desert of Skin Toxicities: A Collaborative Approach

This study highlights the importance of collaboration between dermatologists and oncologists in managing the cutaneous AEs associated with targeted therapies. This collaborative approach is essential for minimizing the impact of these side effects and ensuring the best possible outcomes for patients.

A New Oasis in the Desert: Oncodermatology

This research emphasizes the growing role of oncodermatology clinics in managing the cutaneous AEs associated with targeted therapies. These clinics provide a valuable resource for patients and clinicians, offering a comprehensive approach to managing complex skin toxicities.

Dr.Camel's Conclusion

This study explores the cutaneous adverse events associated with targeted therapies for hematolymphoid malignancies, highlighting the importance of oncodermatology clinics and the collaborative efforts needed to manage these side effects. It's like navigating a complex desert landscape, where collaboration and expertise are essential for ensuring a safe and effective journey for patients.

Date :
  1. Date Completed 2018-07-09
  2. Date Revised 2018-07-09
Further Info :

Pubmed ID

28918995

DOI: Digital Object Identifier

10.1016/j.clml.2017.07.005

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.